Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in AML with del(5q) or Monosomy 5
NCT01198054Phase 4Terminated
- Sponsor
- Fundación PETHEMA
- Start
- Jan 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lenalidomide in acute myeloid leukemia (AML), sponsored by Fundación PETHEMA. Started Jan 2011; status: terminated.
02
Drugs
lenalidomide
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01198054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198054.